GSK Gets $9.3 Million Pricing Fine In India, Criminal Probe At Home In U.K.
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline, dealing with a fresh criminal investigation at home in the U.K., also has been fined in India for its Consumer Healthcare division overcharging for a pain-relief drug.